Last reviewed · How we verify
L-Methionine — Competitive Intelligence Brief
marketed
methionine
S-ribosylhomocysteine lyase
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
L-Methionine (METHIONINE).
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| L-Methionine TARGET | METHIONINE | marketed | methionine | S-ribosylhomocysteine lyase | ||
| S-adenosylmethionine | S-adenosylmethionine | US Department of Veterans Affairs | phase 3 | Methionine derivative |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (methionine class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- L-Methionine CI watch — RSS
- L-Methionine CI watch — Atom
- L-Methionine CI watch — JSON
- L-Methionine alone — RSS
- Whole methionine class — RSS
Cite this brief
Drug Landscape (2026). L-Methionine — Competitive Intelligence Brief. https://druglandscape.com/ci/methionine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab